Literature DB >> 15241891

Cytotoxic epimeric withaphysalins from leaves of Acnistus arborescens.

Maria Leopoldina Veras1, Maria Zeneide B Bezerra, Raimundo Braz-Filho, Otilia Deusdênia L Pessoa, Raquel Carvalho Montenegro, Cláudia do O Pessoa, Manoel Odorico de Moraes, Letícia Veras Costa-Lutufo.   

Abstract

Phytochemical analysis of the leaves of Acnistus arborescens (Solanaceae) resulted in the isolation of two new epimeric withaphysalins (17S,20R,22R)-5beta,6beta: 18,20-diepoxy-4beta,18-dihydroxy-1-oxowitha-24-enolide (2, 18R and 18S), together with the known withaphysalin F (1, 18R and 18S). Their structures were established by spectroscopic methods, including 2D NMR data and comparison with literature data. Compounds 1 and 2 dis-played potent cytotoxic activities against several cancer cell lines with IC50 values in the range of 0.20 to 1.46 microg/mL for 1 and 0.89 to 8.08 microg/mL for 2. The strong cytotoxicity presented by 1 suggests that in this series of compounds, the 2,3-unsaturated ketone moiety is an important pharmacophoric unit. The cytotoxic activity seemed to be related to DNA synthesis inhibition, as revealed by the reduction of 5-bromo-2'-deoxyuridine incorporation after 24 hours of incubation on leukemic cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15241891     DOI: 10.1055/s-2004-827156

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  2 in total

1.  Cell cycle arrest through inhibition of tubulin polymerization by withaphysalin F, a bioactive compound isolated from Acnistus arborescens.

Authors:  Danilo D Rocha; Aruna Balgi; Ana Isabel V Maia; Otilia D Pessoa; Edilberto R Silveira; Letícia V Costa-Lotufo; Michel Roberge; Claudia Pessoa
Journal:  Invest New Drugs       Date:  2011-03-18       Impact factor: 3.850

Review 2.  Natural products as new antimitotic compounds for anticancer drug development.

Authors:  Carlos Roberto Koscky Paier; Sarah Sant'Anna Maranhão; Teiliane Rodrigues Carneiro; Lídia Moreira Lima; Danilo Damasceno Rocha; Renan da Silva Santos; Kaio Moraes de Farias; Manoel Odorico de Moraes-Filho; Claudia Pessoa
Journal:  Clinics (Sao Paulo)       Date:  2018-12-10       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.